Takimoto Chris H 4
4 · IGM Biosciences, Inc. · Filed Dec 20, 2022
Insider Transaction Report
Form 4
Takimoto Chris H
Chief Medical Officer
Transactions
- Sale
Common Stock
2022-12-16$18.77/sh−3,492$65,561→ 32,495 total - Sale
Common Stock
2022-12-16$19.36/sh−1,938$37,519→ 30,557 total
Footnotes (3)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]This transaction was executed in multiple trades at prices ranging from $18.29 to $19.289. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]This transaction was executed in multiple trades at prices ranging from $19.30 to $19.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.